RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 49.38

Change

-0.03 (-0.05)%

Market Cap

N/A

Volume

3.17K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-0.86 (-4.14%)

USD 8.29B
QLD ProShares Ultra QQQ

-3.19 (-3.38%)

USD 6.07B
FNGU MicroSectors FANG+ Index 3X Le..

N/A

USD 5.57B
SSO ProShares Ultra S&P500

-1.80 (-2.12%)

USD 4.37B
UPRO ProShares UltraPro S&P500

-2.45 (-3.17%)

USD 3.08B
TECL Direxion Daily Technology Bull..

-3.00 (-4.48%)

USD 2.48B
YINN Direxion Daily FTSE China Bull..

-0.19 (-0.36%)

USD 1.91B
USD ProShares Ultra Semiconductors

-2.58 (-5.23%)

USD 0.82B
LABU Direxion Daily S&P Biotech Bul..

-5.89 (-7.35%)

USD 0.66B
UDOW ProShares UltraPro Dow30

-1.71 (-1.95%)

USD 0.59B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

+0.29 (+0%)

USD 0.09B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

-0.04 (0%)

USD 8.75B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

+1.15 (+0%)

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+0.45 (+0%)

USD 0.23B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

+0.70 (+0%)

N/A
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.26% 76% C+ 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.26% 76% C+ 90% A-
Trailing 12 Months  
Capital Gain -4.74% 45% F 28% F
Dividend Return 1.49% 81% B- 28% F
Total Return -3.24% 43% F 25% F
Trailing 5 Years  
Capital Gain 152.10% 43% F 78% C+
Dividend Return 6.64% 29% F 11% F
Total Return 158.74% 43% F 75% C
Average Annual (5 Year Horizon)  
Capital Gain 10.79% 25% F 66% D+
Dividend Return 11.14% 25% F 62% D
Total Return 0.35% 23% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 31.28% 97% N/A 33% F
Risk Adjusted Return 35.62% 57% F 49% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.